Discontinuation report MAR-GALANTAMINE ER
Report ID | 148103 |
Drug Identification Number | 02420848 |
Brand name | MAR-GALANTAMINE ER |
Common or Proper name | Galantamine |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | GALANTAMINE |
Strength(s) | 16MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-04-01 |
Remaining supply date | 2017-04-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-10-26 | French | Compare |
v1 | 2021-10-26 | English | Compare |
Showing 1 to 2 of 2